陽普醫療(300030.SZ):擬變更註冊地址、公司名稱等
格隆匯6月15日丨陽普醫療(300030.SZ)公佈,公司於2021 年6月14日召開了第五屆董事會第九次會議和第五屆監事會第八次會議,審議通過了《關於擬變更公司註冊地址、公司名稱及修訂公司章程的議案》,該議案尚需提交公司股東大會審議。
珠海市橫琴新區是經國務院批准設立的國家級新區。作為“一國兩制”下探索粵港澳合作新模式的示範區、深化改革開放和科技創新的先行區、促進珠江口西岸地區產業升級的新平台,國家賦予橫琴新區各項優惠政策。橫琴新區經過近十年發展,基礎設施日臻完善,產業聚集優勢突顯。2015年4月,國務院批准設立的中國(廣東)自貿試驗區掛牌,橫琴新區成為其中重要組成部分,推動橫琴粵澳深度合作區落地建設是落實“珠澳合作開發橫琴”的必然之舉。橫琴具有明顯的區位優勢和環境優勢。
為充分協調利用橫琴新區的優質產業資源及優惠政策,發揮與公司業務發展的協同效應,促進公司與橫琴區互惠互利共同發展,公司與珠海橫琴新區(橫琴自貿試驗區)管理委員會簽署了附條件生效的《戰略合作協議》,公司擬將註冊地由廣州開發區科學城開源大道102號遷入珠海市橫琴新區,在此前提下珠海橫琴新區(橫琴自貿試驗區)管理委員會為公司提供產業、財政、税收和人才等方面的支持,雙方共同打造以精準醫療與智慧醫療為核心的醫療產業集羣。
由於公司註冊地址變更為珠海市橫琴新區環島東路3000號ICC大廈南塔23層,公司將遷出廣州,公司名稱相應更改為“陽普醫療科技股份有限公司”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.